Trials / Completed
CompletedNCT00107757
Seasonal Allergic Rhinitis In Pediatric Subjects
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50mcg and 100mcg for 2 Weeks in Pediatric Subjects Ages 2 to <12 Years With Seasonal Allergic Rhinitis (SAR)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 576 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GW685698X |
Timeline
- Start date
- 2005-03-01
- Completion
- 2005-11-01
- First posted
- 2005-04-08
- Last updated
- 2016-09-15
Locations
65 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00107757. Inclusion in this directory is not an endorsement.